Patent classifications
A01K2227/101
PRODUCTION OF FMDV-RESISTANT LIVESTOCK BY ALLELE SUBSTITUTION
A genetically modified livestock animal comprising a genomic modification to an eIF4G gene. Cells, genes, and proteins encompassing a protease-resistant eIF4G protein or gene.
NANOS knock-out that ablates germline cells
The present invention provides livestock animals and methods to create recipient animals for spermatogonial stem cell transplantation through modulation of the NANOS gene. In one embodiment genome editing issued to create animals with insertions or deletions (indels) that inactivate or otherwise modulate NANOS gene activity so that resulting males lack functional germ cells yet retain functional somatic cells, and females are fertile. These males can then be transplanted with donor spermatogonial stem cells and used for breeding.
TRANSGENIC ANIMALS AND TRANSGENIC EMBRYOS PRODUCING AN ENGINEERED NUCLEASE
The present specification relates to a transgenic animal and a transgenic embryo producing components of an engineered nuclease.
According to the disclosure of the present specification, the transgenic animal (or embryo) producing components of an engineered nuclease is a transgenic animal (or embryo) which includes a first cell having a genome including a first toolbox; and a second cell having a genome including a second toolbox, wherein the first toolbox and the second toolbox include at least one of a polynucleotide encoding an RNA-guided endonuclease and a polynucleotide encoding a guide nucleic acid that is able to specifically bind to a target site, respectively, wherein the first toolbox is present in a first locus of the genome of the first cell; the second toolbox is present in a second locus of the genome of the second cell; and the first locus is different from the second locus.
Production of FMDV-resistant livestock by allele substitution
A genetically modified livestock animal comprising a genomic modification to an eIF4G gene. Cells, genes, and proteins encompassing a protease-resistant eIF4G protein or gene.
MULTIPLEX GENE EDITING
Materials and methods for making multiplex gene edits in cells and are presented. Further methods include animals and methods of making the same. Methods of making chimeric animals are presented, as well as chimeric animals.
Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis
Applicants have discovered a novel induction method for inducing digital dermatitis lesions consistent with the natural disease process. Applicants have prepared a consortium including a macerated tissue culture that may be used in the method as well as a novel inoculation procedure. The consortia of microbes includes isolates of Treponema phagedenis, Porphorymonas, and Bacteroides and the invention includes use of these novel isolates in preventing and treating digital dermatitis. The invention can be used to screen, test or compare the relative efficacy of various drugs and biologics for use in treatment or control of digital dermatitis.
High Efficiency Beef Cattle Having Modified ACTN3 Genes
A bovine animal or offspring thereof or a bovine cell or gene comprising a modified chromosomal sequence in at least one allele of a gene encoding an Alpha-actinin-3 protein, wherein said modified chromosomal sequence partially or completely impairs the ability of said animal/cell/gene to encode said protein. The bovine retains all previous functionality, but is distinguished by a reduction in the number and cross-sectional area of Type II muscle fibers, and an increase in the proportion of Type I muscle fibers, resulting in improved feedlot efficiency, improved meat quality, and reduced emissions output.
METHOD FOR PRODUCING NON-HUMAN LARGE MAMMAL OR FISH EACH CAPABLE OF PRODUCING GAMETE ORIGINATED FROM DIFFERENT INDIVIDUAL
Disclosed is a novel means which makes it possible to steadily mass-produce knockout individuals even in large animals. The method of the present invention is a method for producing a non-human large mammal or fish (non-human animal) that produces gametes originating in a different individual, and comprises transplanting at least one pluripotent cell derived from a second non-human animal into an embryo derived from a first non-human animal, said embryo being at a cleavage stage and having a genome in which a function of nanos3 gene is inhibited, to prepare a chimeric embryo, and allowing said chimeric embryo to develop into an individual. When a pluripotent cell having a genome in which a desired gene is knocked out is used as the pluripotent cell derived from the second non-human animal, the first non-human animal capable of producing germ cells in which the desired gene is knocked out is obtained, and therefore knockout non-human animals can easily be mass-produced by mating such non-human animals.
METHODS FOR MAKING GENETIC EDITS
The present disclosure relates to methods for making genetic edits in vitro in a non-human vertebrate cell or embryo at a plurality of target chromosomal DNA sites. Methods for making a non-human animal having multiplex genetic edits at a plurality of target chromosomal DNA sites and making a non-human vertebrate animal chimeric for host cells and donor cells are also considered.
METHODS OF MODULATING SEX RATIO
Disclosed herein are compositions, methods, and transgenic animals for sex biasing offspring of male animals, as well as methods of screening for sex biasing agents.